ArticleFrontiers in immunology2025

Editorial: Immune-checkpoint inhibitors and immunometabolic reprogramming in cancer immunotherapy.

Vijay Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.